Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation
- PMID: 24133190
- DOI: 10.1093/infdis/jit550
Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation
Abstract
Background: Statins are cholesterol-lowering drugs, targeting HMG-CoA reductase, thereby reducing the risk of coronary disorders and hypercholesterolemia. However, they also can influence immunologic responses.
Methods: Peripheral blood mononuclear cells (PBMCs) and monocyte-derived macrophages (MDMs) were isolated from patients with familial hypercholesterolemia (FH) during statin therapy. After infection of cells with Mycobacterium tuberculosis, bacterial burden was determined. In vivo, mice were treated with statins before aerosol-based infection with M. tuberculosis and were monitored for disease progression.
Results: PBMCs and MDMs from patients with FH receiving statin therapy were more resistant to M. tuberculosis infection, with reduced bacterial burdens, compared with those of healthy donors. Moreover, statin treatment in experimental murine M. tuberculosis infection studies increased host protection, with reduced lung burdens and improved histopathologic findings. Mechanistically, metabolic rescue experiments demonstrated that statins reduce membrane cholesterol levels, particularly by the mevalonate-isoprenoid arm of the sterol pathway. This promoted phagosomal maturation (EEA-1/Lamp-3) and autophagy (LC3-II), as shown by confocal microscopy and Western blot in macrophages. In addition, inhibitors of phagosome and autophagosome maturation reversed the beneficial effect of statins on bacterial growth.
Conclusion: These results suggest that statin-mediated reduction in cholesterol levels within phagosomal membranes counteract M. tuberculosis-induced inhibition of phagosomal maturation and promote host-induced autophagy, thereby augmenting host protection against tuberculosis.
Keywords: Cholesterol; Human; Macrophages; Mice; Mycobacterium tuberculosis.
Similar articles
-
Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape.PLoS One. 2013 Sep 24;8(9):e75490. doi: 10.1371/journal.pone.0075490. eCollection 2013. PLoS One. 2013. PMID: 24086542 Free PMC article.
-
Statin Decreases Helicobacter pylori Burden in Macrophages by Promoting Autophagy.Front Cell Infect Microbiol. 2017 Jan 17;6:203. doi: 10.3389/fcimb.2016.00203. eCollection 2016. Front Cell Infect Microbiol. 2017. PMID: 28144585 Free PMC article.
-
MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.Autophagy. 2017 Feb;13(2):423-441. doi: 10.1080/15548627.2016.1241922. Epub 2016 Oct 20. Autophagy. 2017. PMID: 27764573 Free PMC article.
-
Statin use and impact on tuberculosis risk.Expert Rev Anti Infect Ther. 2021 Sep;19(9):1093-1098. doi: 10.1080/14787210.2021.1892488. Epub 2021 Mar 1. Expert Rev Anti Infect Ther. 2021. PMID: 33641582 Review.
-
Inside or outside the phagosome? The controversy of the intracellular localization of Mycobacterium tuberculosis.Tuberculosis (Edinb). 2012 Mar;92(2):113-20. doi: 10.1016/j.tube.2011.09.009. Epub 2011 Oct 26. Tuberculosis (Edinb). 2012. PMID: 22033468 Review.
Cited by
-
The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis.Antioxid Redox Signal. 2021 Feb 20;34(6):471-485. doi: 10.1089/ars.2020.8124. Epub 2020 Jun 19. Antioxid Redox Signal. 2021. PMID: 32559410 Free PMC article. Review.
-
Autophagy Induction as a Host-Directed Therapeutic Strategy against Mycobacterium tuberculosis Infection.Medicina (Kaunas). 2021 May 23;57(6):522. doi: 10.3390/medicina57060522. Medicina (Kaunas). 2021. PMID: 34070995 Free PMC article. Review.
-
Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria.Antimicrob Agents Chemother. 2016 Sep 23;60(10):6193-9. doi: 10.1128/AAC.00872-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27503643 Free PMC article.
-
Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus.Antibiotics (Basel). 2019 Nov 28;8(4):241. doi: 10.3390/antibiotics8040241. Antibiotics (Basel). 2019. PMID: 31795127 Free PMC article. Review.
-
Statin for Tuberculosis and Pneumonia in Patients with Asthma⁻Chronic Pulmonary Disease Overlap Syndrome: A Time-Dependent Population-Based Cohort Study.J Clin Med. 2018 Oct 24;7(11):381. doi: 10.3390/jcm7110381. J Clin Med. 2018. PMID: 30355982 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous